Malta -
English -
Medicines Authority
ramipril/hydrochlorothiazide tad 2.5 mg/12.5 mg tablets
tad pharma gmbh heinz-lohmann-strasse 5, 27472 cuxhaven, germany - ramipril, hydrochlorothiazide - tablet - ramipril 2.5 mg hydrochlorothiazide 12.5 mg - agents acting on the renin-angiotensin system
Malta -
English -
Medicines Authority
ramipril/hydrochlorothiazide tad 5 mg/25 mg tablets
tad pharma gmbh heinz-lohmann-strasse 5, 27472 cuxhaven, germany - ramipril, hydrochlorothiazide - tablet - ramipril 5 mg hydrochlorothiazide 25 mg - agents acting on the renin-angiotensin system
Malta -
English -
Medicines Authority
ramipril tad 1.25 mg tablets
tad pharma gmbh heinz-lohmann-strasse 5, 27472 cuxhaven, germany - ramipril - tablet - ramipril 1.25 mg - agents acting on the renin-angiotensin system
Malta -
English -
Medicines Authority
ramipril tad 2.5 mg tablets
tad pharma gmbh heinz-lohmann-strasse 5, 27472 cuxhaven, germany - ramipril - tablet - ramipril 2.5 mg - agents acting on the renin-angiotensin system
Malta -
English -
Medicines Authority
ramipril tad 5 mg tablets
tad pharma gmbh heinz-lohmann-strasse 5, 27472 cuxhaven, germany - ramipril - tablet - ramipril 5 mg - agents acting on the renin-angiotensin system
Malta -
English -
Medicines Authority
ramipril tad 10 mg tablets
tad pharma gmbh heinz-lohmann-strasse 5, 27472 cuxhaven, germany - ramipril - tablet - ramipril 10 mg - agents acting on the renin-angiotensin system
European Union -
English -
EMA (European Medicines Agency)
carmustine medac (previously carmustine obvius)
medac gesellschaft für klinische spezialpräparate mbh - carmustine - hodgkin disease; lymphoma, non-hodgkin - antineoplastic agents - carmustine is indicated n adults in the following malignant neoplasms as a single agent or in combination with other antineoplastic agents and/or other therapeutic measures (radiotherapy, surgery): , brain tumours (glioblastoma, brain-stem gliomas, medulloblastoma, astrocytoma and ependymoma), brain metastases, secondary therapy in non-hodgkin’s lymphoma and hodgkin’s disease, as conditioning treatment prior to autologous haematopoietic progenitor cell transplantation (hpct) in malignant haematological diseases (hodgkin’s disease / non-hodgkin’s lymphoma).
Israel -
English -
Ministry of Health
optilast
megapharm ltd - azelastine hydrochloride - eye drops, solution - azelastine hydrochloride 0.05 % - azelastine - azelastine - symptomatic treatment and prevention of seasonal allergic conjunctivitis.
Saudi Arabia -
English -
SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء
elidel 1% cream
meda pharma gmbh & co kg - pimecrolimus - cream - 1 %
Panama -
English -
Ministerio de Salud (Dirección Nacional de Farmacia Y Drogas)
kamillosan crema
meda pharma gmbh & co.kg - extracto de manzanilla ii - extracto de manzanilla ii....2.00 g